​

Encompass Health (EHC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

EHC Stock Forecast

Encompass Health (EHC) stock forecast, based on 27 Wall Street analysts, predicts a 12-month average price target of $150.25, with a high of $155.00 and a low of $144.00. This represents a 23.64% increase from the last price of $121.52.

$65 $83 $101 $119 $137 $155 High: $155 Avg: $150.25 Low: $144 Last Closed Price: $121.52

EHC Stock Rating

Encompass Health stock's rating consensus is Buy, based on 27 Wall Street analysts. The breakdown includes 1 Strong Buy (3.70%), 21 Buy (77.78%), 4 Hold (14.81%), 1 Sell (3.70%), and 0 Strong Sell (0.00%).

Buy
Total 27 1 4 21 1 Strong Sell Sell Hold Buy Strong Buy

EHC Price Target Upside V Benchmarks

TypeNameUpside
StockEncompass Health23.64%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks15.52%

Price Target Trends

1M3M12M
# Anlaysts-38
Avg Price Target-$149.67$149.25
Last Closing Price$121.52$121.52$121.52
Upside/Downside-23.16%22.82%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26112---13
Aug, 26112---13
Jul, 26112---13
Jun, 26112---13
May, 26111---12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 07, 2026David MacDonaldTruist Financial$150.00$125.4319.59%23.44%
Aug 07, 2026UBS$155.00$125.4523.56%27.55%
Aug 06, 2026Barclays$144.00$110.9029.85%18.50%
May 22, 2026Whit MayoLeerink Partners$152.00$104.4545.52%25.08%
May 05, 2026Barclays$140.00$106.6431.28%15.21%
Feb 06, 2026Barclays$153.00$99.5653.68%25.91%
Oct 30, 2025Andrew MokBarclays$150.00$125.6319.40%23.44%
Oct 02, 2025UBS$150.00$124.5220.46%23.44%
Aug 14, 2025David MacDonaldTruist Financial$140.00$119.3017.35%15.21%
Apr 28, 2025RBC Capital$125.00$115.328.39%2.86%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 10, 2026Cowen & Co.BuyBuyhold
Aug 07, 2026UBSBuyBuyhold
Aug 06, 2026BarclaysOverweightOverweighthold
May 28, 2026Cowen & Co.Buyinitialise
Feb 06, 2026BarclaysOverweightOverweighthold
Oct 30, 2025BarclaysOverweightOverweighthold
Oct 02, 2025UBSBuyBuyhold
Sep 16, 2025KeyBancOverweightOverweighthold
Jul 15, 2025KeyBancOverweightOverweighthold
Apr 28, 2025RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.15$2.72$3.54$4.53$5.63---
Avg Forecast$4.30$2.80$3.51$4.30$4.77$5.30$5.57$5.57
High Forecast$4.35$2.82$3.55$4.37$5.15$5.52$5.86$5.63
Low Forecast$4.25$2.77$3.48$4.25$4.49$5.00$5.28$5.49
Surprise %-3.49%-2.86%0.85%5.35%18.03%---

Revenue Forecast

$4B $5B $5B $6B $7B $8B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.01B$4.35B$4.80B$5.37B$5.94B---
Avg Forecast$5.11B$4.33B$4.79B$5.35B$5.83B$6.32B$6.79B$7.19B
High Forecast$5.15B$4.36B$4.80B$5.36B$5.88B$6.33B$6.83B$7.26B
Low Forecast$5.06B$4.30B$4.74B$5.33B$5.77B$6.32B$6.75B$7.11B
Surprise %-21.41%0.34%0.20%0.44%1.86%---

Net Income Forecast

$250M $320M $390M $460M $530M $600M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$412.20M$271.00M$352.00M$455.70M$566.20M---
Avg Forecast$373.96M$357.01M$361.60M$431.50M$485.48M$533.95M$564.24M$564.24M
High Forecast$448.76M$428.41M$433.92M$442.51M$522.11M$559.15M$594.04M$570.57M
Low Forecast$299.17M$285.61M$289.28M$430.33M$455.07M$506.79M$534.44M$555.99M
Surprise %10.22%-24.09%-2.65%5.61%16.63%---

EHC Forecast FAQ

Is Encompass Health stock a buy?

Encompass Health stock has a consensus rating of Buy, based on 27 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 21 Buy, 4 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Encompass Health is a favorable investment for most analysts.

What is Encompass Health's price target?

Encompass Health's price target, set by 27 Wall Street analysts, averages $150.25 over the next 12 months. The price target range spans from $144 at the low end to $155 at the high end, suggesting a potential 23.64% change from the previous closing price of $121.52.

How does Encompass Health stock forecast compare to its benchmarks?

Encompass Health's stock forecast shows a 23.64% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (15.52%).

What is the breakdown of analyst ratings for Encompass Health over the past three months?

  • September 2026: 7.69% Strong Buy, 92.31% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 7.69% Strong Buy, 92.31% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 7.69% Strong Buy, 92.31% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Encompass Health’s EPS forecast?

Encompass Health's average annual EPS forecast for its fiscal year ending in December 2026 is $5.3, marking a -5.86% decrease from the reported $5.63 in 2025. Estimates for the following years are $5.57 in 2027, and $5.57 in 2028.

What is Encompass Health’s revenue forecast?

Encompass Health's average annual revenue forecast for its fiscal year ending in December 2026 is $6.32B, reflecting a 6.52% increase from the reported $5.94B in 2025. The forecast for 2027 is $6.79B, and $7.19B for 2028.

What is Encompass Health’s net income forecast?

Encompass Health's net income forecast for the fiscal year ending in December 2026 stands at $533.95M, representing a -5.70% decrease from the reported $566.2M in 2025. Projections indicate $564.24M in 2027, and $564.24M in 2028.